Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-01
2000-07-18
Mach, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514337, 514338, 514339, 514341, 514342, 514343, A61K 3144, A61K 3141
Patent
active
060908289
ABSTRACT:
A class of 5-arylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds is described for use in treatment of circulatory disorders such as hypertension. Compounds of particular interest are angiotensin II antagonists of the formula ##STR1## wherein A is selected from ##STR2## wherein m is one; wherein R.sup.1 is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, benzyl, cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein R.sup.2 is selected from ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, 4-methylbutyl, tert-butyl, n-pentyl, neo-pentyl, 1-oxoethyl, 1-oxopropyl, 1-oxobutyl, 1-oxopentyl, 1,1-dimethoxypropyl, 1,1-dimethoxypentyl, halo, difluoromethyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, cyclohexanoyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and butylthio; wherein each of R.sup.3, R.sup.4, R.sup.6 through R.sup.11 is hydrido and R.sup.5 is selected from COOH, SH, PO.sub.3 H.sub.2, SO.sub.3 H, CONHNH.sub.2, CONHNHSO.sub.2 CF.sub.3, OH, ##STR3## wherein each of R.sup.42 and R.sup.43 is independently selected from chloro, cyano, nitro, trifluoromethyl, methoxycarbonyl and trifluoromethylsulfonyl.
REFERENCES:
Chemical Abstracts 126:152804, abstract of Maclaughlan, WO 9610258, 1996.
Chemical Abstracts 126:152803, abstract of Alexander, WO 9610257, 1996.
Chemical Abstracts 126:152800, abstract of McMahon, WO 9640256, 1996.
Chemical Abstracts 126:139886, abstract of Egan, WO 9640255, 1996.
Chemical ABstracts 124:176107. abstract of Reitz, US Patent #5,451,593, 1995.
Chemical Abstracts 118:38927, abstract of Reitz, EP 504888, 1992.
LandOfFree
5-aryleheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-aryleheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-aryleheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2037482